Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
NeuBase Therapeutics, Inc. See All Filings	D	2023-07-07 16:11:19 UTC
Amount To Be Raised $5,000,002 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001173281 Filed Document 0001104659-23-079123 Exclusions or Exemptions 506b Accepted Date 2023-07-07 16:11:19 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets $No Revenues Type of Security Equity
Ohr Pharmaceutical Inc See All Filings	D	2014-12-29 00:00:00 UTC
Amount To Be Raised $50,000 Associated Brokers / Dealers N/A CIK Number 0001173281 Filed Document 0001387131-14-004164 Exclusions or Exemptions 506b Accepted Date 2014-12-29 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
Ohr Pharmaceutical Inc See All Filings	D	2014-06-03 00:00:00 UTC
Amount To Be Raised $25,180,224 Associated Brokers / Dealers N/A CIK Number 0001173281 Filed Document 0001387131-14-002124 Exclusions or Exemptions 506b Accepted Date 2014-06-03 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
Ohr Pharmaceutical Inc See All Filings	D	2014-01-16 00:00:00 UTC
Amount To Be Raised $569,581 Associated Brokers / Dealers N/A CIK Number 0001173281 Filed Document 0001387131-14-000154 Exclusions or Exemptions 506b Accepted Date 2014-01-16 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Option To Acquire
Ohr Pharmaceutical Inc See All Filings	D	2013-10-11 00:00:00 UTC
Amount To Be Raised $376,915 Associated Brokers / Dealers N/A CIK Number 0001173281 Filed Document 0001387131-13-003788 Exclusions or Exemptions 506b Accepted Date 2013-10-11 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity